Nerve Regeneration Market: Facts, Figures and Analytical Insights, 2020 to 2024

 Nerve repair and regeneration is a biological process that occurs after a severe nerve injury. Nerve repairing take time and the type of injury that occurred. Sometimes the fatal intervention is required. Most of the time during nerve regeneration doctors recommend relief painkillers and products for recovery of outer injuries leading to relief on underlying effected nerves. The nerve repair and regeneration market have been on rising since the last few years due to the highly unhealthy lifestyle people have adapted these days witnessing new and deadly illness all around. Hereditary transfer of nerve disorders and other neurobiological disorders are leading factors for the rise of nerve repair and regeneration market size.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1202 

The Global Nerve Regeneration Market is reported to forecast a CAGR of more than 11.34% by the year 2024. The market is expected to see revenue of more than 10,000 million US dollars because of high support from government sectors in providing funds and pre-approved FDA’s. Many private firms have also extended support to market the growth of nerve repair market size. With technological advancements in the field of healthcare, doctors have made commendable advancements in the field paving way for nerve regeneration studies.

Segment Analysis

The global nerve regeneration market has been segmented based on product, application, and end user. Based on product, the market has been segregated into neurostimulation and neuromodulation devices, and biomaterials. Based on neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices has been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric Electrical Stimulation. External neurostimulation devices has been further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Biomaterials has been further divided into nerve conduits, nerve protectors, and nerve wraps, nerve connectors. Based on application, the market has been classified as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries has been categorized as internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end user, the market has been divided into end user, hospitals & clinics, ambulatory surgery centers, and others.

Market Players

Market Research Future (MRFR) recognizes Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic as the key players in the global nerve regeneration market.

Regional Analysis

The global nerve regeneration market, based on the region, has been separated into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest share of the global nerve regeneration market during the forecast period. This is owing to the presence of key market players; strategic acquisitions by major players for enhancing product portfolio; increasing cases of chronic pain, obesity, and addiction; and availability of technologically advanced devices for the diagnosis and treatment of nerve disorders.

Europe is expected to witness significant growth in the nerve regeneration market. Various factors such as an increase in the healthcare expenditure by these nations and wide adoption of nerve regeneration techniques due to their efficiency to reduce pain and increasing cases of cancer are propelling the market growth.

Asia-Pacific is projected to be the fastest-growing region in the global nerve regeneration market due to increasing awareness of neurological disorders and their risk factors, rising prevalence of osteoporosis, cancer, and neurological disorders. According to an article published by the International Osteoporosis Foundation, osteoporosis affects almost 70 million Chinese citizens over the age of 50 and is responsible for nearly 687,000 hip fractures in China each year.

The nerve regeneration market in the Middle East & Africa region is likely to exhibit the lowest growth due to factors such as large patient population suffering from neurological disorders, technological advancements, growth of the healthcare sector, and increasing healthcare expenditure.

Key Findings of the Study:

• The global nerve regeneration market was valued at USD 6665.78 million in 2018, is estimated to grow at USD 25 million by 2024 at a CAGR of 11.34% during the assessment period.

• Americas accounted for the largest share of the global nerve regeneration market due to the presence of key market players in the region.

• Based on the product, the neurostimulation and neuromodulation devices segment accounted for the largest market share of USD 4,764.96 million in 2018.

• Based on end user, the hospitals & clinics segment dominated the market and projected to register the highest CAGR of 11.62% during the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202 

Tissue Microarray Market Top Companies, Business Insights, Growth, Global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis 2023

 The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1213 

The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.

Major Players in the tissue microarray Market

Some of the key players in the global market are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp, and general electric and others.

The global tissue microarray market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas is the leading market across the globe on account of constantly increasing cancer patient population, increasing number of cases in children, and increasing government support for research in healthcare domain and it is likely to flourish the Americas market over the review period.

Europe holds the second position in the market due to development in healthcare domain. During the last 30 years, in Europe biotechnology industry has developed gradually. Even though in Germany federal support programs started very early to target biotechnology, the innovative performance of this sector has been lagging behind that of the US, where the federal support was less direct earlier. Advances in technology in the healthcare sector have minimized human effort and increased the quality of patient care services, which will boost the market growth.

Asia Pacific is expected to be the fastest growing market owing to the concentration of emerging player and focus of established market leaders in this region. Moreover, the rising incidence of cancer in Asia Pacific has prompted suppliers and manufacturers to expand their market reach and to enter emerging markets. According to the Centers for Disease Control and Prevention (CDC), life-threatening or chronic diseases such as stroke, heart disease, cancer, diabetes, and chronic respiratory diseases, kidney diseases were the leading cause of death in 2014.  

On the other hand, the Middle East & Africa owns the minimum market share of the tissue microarray market due to less development in healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Segmentation

The global tissue microarray market is segmented on the basis of procedure, technology, application, and end user.

On the basis procedure, it is segmented into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array.

On the basis of technology, it is segmented into DNA microarray, polymerase chain reaction, next-generation sequencing,     northern blotting, and western blotting.

On the basis of application, it is segmented in to oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, and comparative genomic hybridization, and sequencing bioinformatics.

On the basis of end user, it is segmented into pharmaceutical and biotechnological companies, research organization, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213 

Automated Hospital Beds Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2027

 The Global Automated Hospital Beds Market is expected to register a CAGR of 5.97% and is anticipated to reach USD 2,553.4 million by 2023. 

Automated hospital beds are specially designed for hospitalized patients in need of some form of health care services. These hospitals beds have special features both for the comfort and well-being of the patient and for the convenience of health care workers. Most common features of automated hospital beds are automated adjustable height for the entire bed including the head and the feet, adjustable side rails, and electronic buttons to operate both the bed and other nearby electronic devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4250 

The increase in the number of various acute and chronic disorders, rising geriatric population, increased number of obese people, continuous development in the designs of the hospital beds for the betterment and more comfort of the patients, and rising healthcare expenditure are the major drivers propelling market growth. However, the high cost of automated hospital beds and expensive maintenance of automated hospital beds are hampering the growth of the market.

Automated hospital beds are more convenient and user-friendly than the traditional hospital beds. Automated hospital beds are designed to meet needs of the patients proficiently for different situations. The hospital electric beds are highly adjustable, comfortable and flexible. Developed regions such as the Americas and Europe accounted for the major market share due to technological development in the healthcare sector. These beds work with minimal assistance and are self-controlled, which makes handling them easy, a less laborious task than the manual beds.

Various medical emergencies such as accidents on roads, industrial mishaps, wars, and natural calamities which provides huge opportunities for the hospitals to improve their promptness to tackle such medical emergencies. Hospitals and other healthcare emergency centres have increased their required facilities to handle emergencies which will fuel the market growth. Furthermore, the growth of emergency departments to meet the rising medical emergencies will drive the demand for automated hospital beds. For instance, many hospitals have separate rooms for operating emergency cases, and in case of surgery with the help of automated hospital beds surgeries can be performed immediately.

The increasing prevalence of life-threating diseases drives admission rates in healthcare facilities. To meet the unmet demand for healthcare facilities, manufacturers and suppliers are introducing advanced automated products and thus increasing the market penetration in the automated hospital beds sector. The rising incidence of life-threating diseases in Asia Pacific and the Middle East & Africa has prompted suppliers and manufacturers to expand their market reach and to enter in emerging markets. According to the Centers for Disease Control and Prevention (CDC), life-threatening or chronic diseases such as stroke, heart diseases, diabetes, and chronic respiratory diseases, kidney diseases were the leading cause of death in 2014. For example, according to the Center of Disease Control and Prevention, each year, nearly 4.9 million adults with diagnosed kidney disease.

ArjoHuntleigh, Gendron Inc., Hill-Rom, Invacare Corporation, Linet spol. s r.o., Medline Industries, Inc., Paramount Bed Holdings Co., Ltd., and Stryker and others are some of the major players in the Global Automated hospital beds Market.

Global Automated hospital beds Market   - Regional Analysis

Market opportunities are those unexploited factors that are expected to boost the growth of the market. These factors can be referred to as the untapped drivers of the market. The major opportunities for the automated hospital beds are the introduction in developing economies.

Introduction of smart hospital bed is one of the emerging opportunities for the global automated hospital beds market. Smart bed advancements will improve patient safety and comfort throughout the hospital stay.

The demand for the automated hospital beds is increasing due to its easier and more sophisticated for patients in developing countries that include Asia Pacific and the Middle East & African countries. These developing countries are suffering with immense disease burden. These diseases include asthma, cardiac failure, chronic obstructive pulmonary disease, chronic kidney disease, coronary artery disease, multiple sclerosis, Parkinson’s disease and others resulting increasing in-patient population in hospitals.

Governments of few developing countries have taken educational initiatives and projects such as the Janala Project (Bangladesh), ProjectABC (Nigeria), Tostan (Senegal), Yoza (South Africa), and BridgeIT (Tanzania) among others. These programs are focused to improve literacy and create awareness about health that help to increase the understanding of people and raises chances of becoming technically mature. These factors will indirectly boost the market growth for automated hospital beds.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/automated-hospital-beds-market-4250 

Capillary Blood Collection Devices Market to Reap Excessive Revenues by 2020-2027

 Global Capillary Blood Collection Devices Market is anticipated to record a CAGR of 10.3% while garnering a market value of USD 778.38 Million by 2027, asserts Market Research Future (MRFR).

Impact of COVID-19

The outbreak of COVID-19 brought a significant impact on the capillary blood collection devices industry. The lockdown imposed during the pandemic hampered the production and supply chain owing to the temporary shutdown of the manufacturing units.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4213 

However, the risk associated with capillary blood assortment techniques and blood contaminations may hinder the growth of the market to an extent.

Global capillary blood collection devices market is expected to grow at a CAGR of 10.0% during the forecast period 2017–2023.

Key Players in the Malocclusion Market

Some of key the players in the capillary blood collection devices market are F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Novo Nordisk A S, Becton Dickinson and Company, Medtronic PLC, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., Terumo Corporation, Ypsomed Holding AG, HTL-STREFA S.A., Sarstedt AG & Co, Owen Mumford Ltd., Greiner Bio-One, Improve Medical, Chengdu Rich Science Industry Co., Ltd., Weigao Group, Nipro, Medigard, Weihai Hongyu Medical Devices, and others.

Regional Analysis

The global capillary blood collection devices market is segmented on the basis of regions, namely, America, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate the capillary blood collection devices market owing to the high healthcare expenditure, growing demand for diagnosis of chronic diseases, and well-developed technology. The incidence of contagious diseases is increasing rapidly on a global level, some of these diseases include Hantavirus pulmonary syndrome, HIV/AIDS, Lyme disease, hemolytic uremic syndrome. The need to monitor along with the requirement of advanced techniques for diagnostic testing of non-contagious diseases such as diabetes mellitus, chronic kidney diseases, lung disease, and some heart diseases are expected to impact the growth of the global capillary blood collection devices market.

Europe holds the second position in the capillary blood collection devices market. It is expected that the economic support provided by the government and private bodies for R&D, increasing the incidence of diabetes, and presence of leading market players are propelling the growth of the capillary blood collection devices market in the European region. For instance, Medtronic, an Ireland based company, is a global healthcare solution company that provides a multitude of products. The product. In January 2015, the company completed the acquisition of Covidien plc tap new markets.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology, and rising prevalence of Diabetes drive the growth of this market in Asia Pacific region. According to the 2013 statistics suggested by The Diabetes Atlas, around 366 million people are affected by diabetes in the Asian region.

The Middle East and Africa hold the least share of the capillary blood collection devices market owing to the presence of poor and slow developing countries, especially, in the African region.

Segmentation

The global capillary blood collection devices market is segmented on the basis of material, type of devices, and end user.

On the basis of the material, the market is classified into plastic, glass, stainless steel, and others.

On the basis of type of devices, the market is segmented into blood collecting tubes and collector, lancets, and warming devices.

On the basis of end-user, the market is segmented into hospitals, clinics, diagnostic centers and pathology laboratories, home diagnostics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/capillary-blood-collection-devices-market-4213 

Medical Automation Market : Dynamics, Segments, Size and Demand, 2020–2027

 Global Medical Automation Market is expected to register a CAGR of 7.0% and is anticipated to reach USD 42.28 Billion by 2023. New robotic surgical procedures and increasing healthcare costs are major factors that are driving the demand in this sector.

COVID-19 Analysis

The COVID-19 is posing the biggest threat to the healthcare sector in modern years, and digital transformation will climb to the top of the business agenda. The influence of COVID-19 is pervasive, being felt in all major fields of science, politics, and technology. Artificial intelligence and robots are here to stay and their impact on healthcare systems are going to escalate. Health care facilities around the country are facing a shortage due to the overwhelming number of COVID-19 patients. When staffing becomes more limited, software robots and artificial intelligence are used to assist in the distribution of resources, ensure protection and drive efficiencies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5184 

Segmentation

The global medical automation market is segmented on the basis of type, and end users.

On the basis of type, the market is segmented into diagnostic & monitoring automation, therapeutic automation, lab & pharmacy automation, medical logistics & training, and others. The diagnostic & monitoring automation segment is sub-segmented into automated imaging, point-of-care testing (POCT), automated image analysis, and others. The therapeutic automation segment is sub-segmented into non-surgical automation, surgical automation, and others. The medical logistics & training segment is sub-segmented into logistic automation, trainers, and others.

On the basis of end users, the market is segmented into hospitals and diagnostic centers, pharmacies, research labs & institutes, research labs & institutes, and others.   

Regional Analysis

The Americas dominate the global medical automation market owing to an increasing prevalence of the diseases like cancer, diabetes, and others. Moreover, growing biotechnology and biopharmaceutical sector within the region is fuelling the market during the forecast period. In 2016 according to the National Cancer Institute, approximately 1,685,210 new cases of cancer were diagnosed in the United States and approximately 595,690 deaths were reported due to the same, Europe is the second largest market for the global medical automation. The market growth in the European region is facilitated by the presence of developed economies. Huge patient population and rising healthcare expenditure within the region is further fuelling the market growth within the region. In Asia Pacific region growing biotech and biopharmaceutical factor, increasing patient population and rising healthcare expenditures along with the increasing demands for the robotic surgery is driving the market growth. Moreover, favorable government policies are boosting the market growth within the region. The Middle East & Africa & Africa holds the least market share. This can be attributed to the presence of the low per capita income and stringent government policies, especially within the African region. 

Key Players

The key players in the global medical automation market are Koninklijke Philips N.V., Siemens AG, GENERAL ELECTRIC, Medtronic, Stryker, Danaher, Accuray Incorporated, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-automation-market-5184 

Trends in the Cell Culture Media Market 2020-2027

 The Global Cell Culture Media Market is expected to register a CAGR of 6.9% and is projected to reach USD 2,070.71 million by 2023. A cell culture media is a growth media designed to support the growth of cells. A cell culture media is composed of the appropriate composition of amino acids, vitamins, inorganic salts, glucose, serum, etc. It may require additional supplementary reagents and sera such as growth factors, hormones, lipids, trace elements, and minerals which are necessary for cell cultures to grow and survive in their incubation environment.

The cell culture media market is driven by the growing pharmaceutical industry, rising biopharmaceutical drugs in the pipeline, increasing prevalence of cancer and infectious diseases, and increasing geriatric population. However, the cost of cell culture media and contamination of media are a threat to the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4462 

Market Dynamics

Rising research and development in the pharmaceutical and biotechnology industry is driving the growth of the cell culture media market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research and development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over Euro 4.1 billion in 2015 just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases. This growing research and development in the field of healthcare are leading to an upward demand for cell culture media.

Segmentation

The global cell culture media market has been segmented into product type, application, and end user. By product type, the market has been segregated into reagents, media, and sera. Based on media, the market has been divided into classical media, stem cell media, serum-free media, and others. The market, based on stem cell media, is further categorized as bone marrow, neural stem cells (NSCs), mesenchymal stem cells (MSCs), and embryonic stem cells (ESCs).

Based on application, the market has been bifurcated into biopharmaceutical, tissue-culture and manufacturing, gene therapy, cytogenetic, and others. By end user, the market has been classified as biopharmaceutical companies, academic and research laboratories, hospitals and diagnostics centers, and others.

Key Players

The major players in the global cell culture media market are Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), GE Healthcare (US), Becton, Dickinson and Company (US), HiMedia Laboratories (India), Corning Incorporated (US), PromoCell (Germany), Sera Scandia A/S (Denmark), The Sartorius Group (Germany), and Fujifilm Holdings Corporation (Japan).

Some of the key strategies followed by the players operating in the global cell culture media market were mergers, acquisitions, and new product launches.

Regional Analysis

The global cell culture media market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted for the largest share in the global cell culture media market. The large share is majorly attributed to the presence of major manufacturers, increasing the prevalence of diseases leading to the high demand for drugs and other medications, technological advancements in the preclinical and clinical segment, increasing awareness among the population, and high disposable income.

The European market for cell culture media is projected to be the second-largest during the forecast period. Rising government initiatives to promote research to find a cure to the increasing number of chronic diseases, increasing number of pharmaceutical manufacturers, improving economies, and increased healthcare spending are driving the growth of the market in this region.

The Asia-Pacific region accounted for the third-largest market share due to many research organizations, low manufacturing cost, low labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India. The Australian market for cell culture media is expected to hold a market share of 10.7% in 2017.

The Middle East & Africa with less economic developments and meager income accounted for the least market share in 2017 but is expected to grow because of increasing awareness among people and demand for better healthcare facilities in the countries along with the rising disposable income.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cell-culture-media-market-4462 

Blockchain in Pharmaceutical Supply Chain Management Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2027

 The Global Blockchain in Pharmaceutical Supply Chain Management Market is expected to register a CAGR of 22.5% during the forecast period of 2019 to 2024.

A blockchain solution can make a substantive difference to the pharmaceutical supply chain. At every stage of the supply chain process, barcodes would be scanned and recorded onto a blockchain ledger system which, in sequence, records and creates an audit trail of the drug journey. Sensors can also be combined into the supply chain, with temperature or humidity being noted onto the ledger system. This is most important for drugs requiring fridge storage, such as insulin or expensive, specially manufactured medicines.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8009 

Furthermore, through the use of blockchain, the supply chain process of the drugs can become more secure and streamlined. Every delivery can be tracked, with the delivery driver traced through biometric measures. Every checkpoint concerning the drugs supply is recorded and traced via biometric measures, 2d barcode scans, or sensor technology. As the drug is tracked from its manufacturing unit to the patient, the whole of the drug supply chain becomes seamless, precise, audited, and safe.

Segmentation

The global blockchain in pharmaceutical supply chain management is segmented on the basis of application, end user, and region.

On the basis of application, the global blockchain in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management, payment & settlement, others. The market by end user is segmented into manufacturers, distributors, healthcare providers

On the bases of region, the global blockchain in pharmaceutical supply chain management market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to hold the largest market share and the Middle East & Africa with a low market share during the forecasted period.

Key Players

Some of the key players in the global blockchain in pharmaceutical supply chain management market are IBM, Microsoft, SAP SE, Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation, Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury, Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger and others.

Regional Analysis

The healthcare sector and its supporting IT infrastructure are going through dramatic changes, all of which impact the claims management process and lead to improving the technology. Many healthcare organizations use robotic process automation, intelligent EDI integration, insurance discovery, and patient solutions all within their workflow platform to dramatically enhance the overall process. The adoption of various software has increased profit.

Infrastructure and technology are continuously evolving in developing regions such as Asia-Pacific. A number of different multinational and local companies are involved in developing their markets in this region owing to the developing economy and increasing government support. An increasing number of healthcare companies have provided a good opportunity for the development of the blockchain in pharmaceutical supply chain management market.

Furthermore, in the United States, the Drugs Quality and Safety Act (DQSA) was promoted by Congress on November 27, 2013. This outlines the steps to be taken to develop an interoperable electronic supply chain management system. This will strengthen the FDA's capability to protect consumers from exposure to drugs that could be fake or from the black market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/blockchain-pharmaceutical-supply-chain-management-market-8009